TGRX-326 Pharmacokinetic Drug Interaction

NCT06294561 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Itraconazole+TGRX-326
DRUG: Efavirenz+TGRX-326

Sponsor

Shenzhen TargetRx Co., Ltd.

Collaborators

[object Object]